Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 55

1.

Novel VPS33B mutation in a patient with autosomal recessive keratoderma-ichthyosis-deafness syndrome.

Alter S, Hotz A, Jahn A, Di Donato N, Schröck E, Smitka M, von der Hagen M, Schallner J, Menschikowski M, Gillitzer C, Laass MW, Fischer J, Tzschach A.

Am J Med Genet A. 2018 Dec;176(12):2862-2866. doi: 10.1002/ajmg.a.40634. Epub 2018 Dec 18. Review.

PMID:
30561130
2.

Identification of rare levels of methylated tumor DNA fragments using an optimized bias based pre-amplification-digital droplet PCR (OBBPA-ddPCR).

Menschikowski M, Jandeck C, Friedemann M, Nacke B, Hantsche S, Tiebel O, Sukocheva O, Hagelgans A.

Oncotarget. 2018 Nov 16;9(90):36137-36150. doi: 10.18632/oncotarget.26315. eCollection 2018 Nov 16.

3.

Diverse effects of phospholipase A2 receptor expression on LNCaP and PC-3 prostate cancer cell growth in vitro and in vivo.

Friedemann M, Nacke B, Hagelgans A, Jandeck C, Bechmann N, Ullrich M, Belter B, Neuber C, Sukocheva O, Pietzsch J, Menschikowski M.

Oncotarget. 2018 Nov 13;9(89):35983-35996. doi: 10.18632/oncotarget.26316. eCollection 2018 Nov 13.

4.

Regulatory role of sphingosine kinase and sphingosine-1-phosphate receptor signaling in progenitor/stem cells.

Ng ML, Yarla NS, Menschikowski M, Sukocheva OA.

World J Stem Cells. 2018 Sep 26;10(9):119-133. doi: 10.4252/wjsc.v10.i9.119. Review.

5.

Metabolome-guided genomics to identify pathogenic variants in isocitrate dehydrogenase, fumarate hydratase, and succinate dehydrogenase genes in pheochromocytoma and paraganglioma.

Richter S, Gieldon L, Pang Y, Peitzsch M, Huynh T, Leton R, Viana B, Ercolino T, Mangelis A, Rapizzi E, Menschikowski M, Aust D, Kroiss M, Beuschlein F, Gudziol V, Timmers HJ, Lenders J, Mannelli M, Cascon A, Pacak K, Robledo M, Eisenhofer G, Klink B.

Genet Med. 2019 Mar;21(3):705-717. doi: 10.1038/s41436-018-0106-5. Epub 2018 Jul 27.

6.

Identification and Quantification of Heterogeneously-methylated DNA Fragments Using Epiallele-sensitive Droplet Digital Polymerase Chain Reaction (EAST-ddPCR).

Menschikowski M, Jandeck C, Friedemann M, Richter S, Thiem D, Lange BS, Suttorp M.

Cancer Genomics Proteomics. 2018 Jul-Aug;15(4):299-312. doi: 10.21873/cgp.20088.

7.

Identification of CpG Sites of SERPINA5 Promoter with Opposite Methylation Patterns in Benign and Malignant Prostate Cells.

Hagelgans A, Jandeck C, Friedemann M, Donchin A, Richter S, Menschikowski M.

Anticancer Res. 2017 Dec;37(12):6609-6618.

PMID:
29187436
8.

Current insights into functions of phospholipase A2 receptor in normal and cancer cells: More questions than answers.

Sukocheva O, Menschikowski M, Hagelgans A, Yarla NS, Siegert G, Reddanna P, Bishayee A.

Semin Cancer Biol. 2019 Jun;56:116-127. doi: 10.1016/j.semcancer.2017.11.002. Epub 2017 Nov 2. Review.

PMID:
29104026
9.

Methods for comparing multiple digital PCR experiments.

Burdukiewicz M, Rödiger S, Sobczyk P, Menschikowski M, Schierack P, Mackiewicz P.

Biomol Detect Quantif. 2016 Aug 10;9:14-9. doi: 10.1016/j.bdq.2016.06.004. eCollection 2016 Sep.

10.

Epigenetic control of group V phospholipase A2 expression in human malignant cells.

Menschikowski M, Hagelgans A, Nacke B, Jandeck C, Mareninova OA, Asatryan L, Siegert G.

Tumour Biol. 2016 Jun;37(6):8097-105. doi: 10.1007/s13277-015-4670-x. Epub 2015 Dec 29.

PMID:
26715269
11.

Epigenetic control of phospholipase A2 receptor expression in mammary cancer cells.

Menschikowski M, Hagelgans A, Nacke B, Jandeck C, Sukocheva O, Siegert G.

BMC Cancer. 2015 Dec 16;15:971. doi: 10.1186/s12885-015-1937-y.

12.

Epigenetic Mutation of the Succinate Dehydrogenase C Promoter in a Patient With Two Paragangliomas.

Richter S, Klink B, Nacke B, de Cubas AA, Mangelis A, Rapizzi E, Meinhardt M, Skondra C, Mannelli M, Robledo M, Menschikowski M, Eisenhofer G.

J Clin Endocrinol Metab. 2016 Feb;101(2):359-63. doi: 10.1210/jc.2015-3856. Epub 2015 Dec 11.

PMID:
26652933
13.

Silibinin down-regulates expression of secreted phospholipase A2 enzymes in cancer cells.

Hagelgans A, Nacke B, Zamaraeva M, Siegert G, Menschikowski M.

Anticancer Res. 2014 Apr;34(4):1723-9.

PMID:
24692702
14.

Opposing effects of HIF1α and HIF2α on chromaffin cell phenotypic features and tumor cell proliferation: Insights from MYC-associated factor X.

Qin N, de Cubas AA, Garcia-Martin R, Richter S, Peitzsch M, Menschikowski M, Lenders JW, Timmers HJ, Mannelli M, Opocher G, Economopoulou M, Siegert G, Chavakis T, Pacak K, Robledo M, Eisenhofer G.

Int J Cancer. 2014 Nov 1;135(9):2054-64. doi: 10.1002/ijc.28868. Epub 2014 Apr 7.

15.

Novel parameters of extended complete blood cell count under fluorescence flow cytometry in patients with sepsis.

Arneth BM, Ragaller M, Hommel K, Tiebel O, Menschikowski M, Siegert G.

J Clin Lab Anal. 2014 Mar;28(2):130-5. doi: 10.1002/jcla.21656. Epub 2014 Jan 6.

16.

Serum amyloid A, phospholipase A₂-IIA and C-reactive protein as inflammatory biomarkers for prostate diseases.

Menschikowski M, Hagelgans A, Fuessel S, Mareninova OA, Asatryan L, Wirth MP, Siegert G.

Inflamm Res. 2013 Dec;62(12):1063-72. doi: 10.1007/s00011-013-0665-5. Epub 2013 Sep 24.

PMID:
24061501
17.

Plasma levels of phospholipase A2-IIA in patients with different types of malignancies: prognosis and association with inflammatory and coagulation biomarkers.

Menschikowski M, Hagelgans A, Schuler U, Froeschke S, Rosner A, Siegert G.

Pathol Oncol Res. 2013 Oct;19(4):839-46. doi: 10.1007/s12253-013-9652-y. Epub 2013 Jun 1.

PMID:
23722320
18.

Deregulated expression of urokinase and its inhibitor type 1 in prostate cancer cells: role of epigenetic mechanisms.

Hagelgans A, Menschikowski M, Fuessel S, Nacke B, Arneth BM, Wirth MP, Siegert G.

Exp Mol Pathol. 2013 Jun;94(3):458-65. doi: 10.1016/j.yexmp.2013.03.006. Epub 2013 Mar 27.

PMID:
23541763
19.
20.

Aberrant methylation of the M-type phospholipase A(2) receptor gene in leukemic cells.

Menschikowski M, Platzbecker U, Hagelgans A, Vogel M, Thiede C, Schönefeldt C, Lehnert R, Eisenhofer G, Siegert G.

BMC Cancer. 2012 Dec 5;12:576. doi: 10.1186/1471-2407-12-576.

21.

Regulation of thrombomodulin expression in prostate cancer cells.

Menschikowski M, Hagelgans A, Tiebel O, Vogel M, Eisenhofer G, Siegert G.

Cancer Lett. 2012 Sep 28;322(2):177-84. doi: 10.1016/j.canlet.2012.03.001. Epub 2012 Mar 7.

PMID:
22406829
22.

Serum levels of secreted group IIA phospholipase A(2) in benign prostatic hyperplasia and prostate cancer: a biomarker for inflammation or neoplasia?

Menschikowski M, Hagelgans A, Fuessel S, Mareninova OA, Neumeister V, Wirth MP, Siegert G.

Inflammation. 2012 Jun;35(3):1113-8. doi: 10.1007/s10753-011-9418-1.

PMID:
22189868
23.

Expression and shedding of endothelial protein C receptor in prostate cancer cells.

Menschikowski M, Hagelgans A, Tiebel O, Klinsmann L, Eisenhofer G, Siegert G.

Cancer Cell Int. 2011 Feb 15;11:4. doi: 10.1186/1475-2867-11-4.

24.

Reducing agents induce thrombomodulin shedding in human endothelial cells.

Menschikowski M, Hagelgans A, Eisenhofer G, Tiebel O, Siegert G.

Thromb Res. 2010 Aug;126(2):e88-93. doi: 10.1016/j.thromres.2010.05.006.

PMID:
20605193
25.

Regulation of endothelial protein C receptor shedding by cytokines is mediated through differential activation of MAP kinase signaling pathways.

Menschikowski M, Hagelgans A, Eisenhofer G, Siegert G.

Exp Cell Res. 2009 Sep 10;315(15):2673-82. doi: 10.1016/j.yexcr.2009.05.015. Epub 2009 May 23.

PMID:
19467228
26.

Involvement of epigenetic mechanisms in the regulation of secreted phospholipase A2 expressions in Jurkat leukemia cells.

Menschikowski M, Hagelgans A, Kostka H, Eisenhofer G, Siegert G.

Neoplasia. 2008 Nov;10(11):1195-203.

27.
28.

On interaction of activated protein C with human aortic smooth muscle cells attenuating the secretory group IIA phospholipase A2 expression.

Menschikowski M, Hagelgans A, Hempel U, Lattke P, Ismailov I, Siegert G.

Thromb Res. 2008;122(1):69-76. Epub 2007 Oct 22.

PMID:
17936881
29.

Mechanism of inhibition of human secretory phospholipase A2 by flavonoids: rationale for lead design.

Lättig J, Böhl M, Fischer P, Tischer S, Tietböhl C, Menschikowski M, Gutzeit HO, Metz P, Pisabarro MT.

J Comput Aided Mol Des. 2007 Aug;21(8):473-83. Epub 2007 Aug 15.

PMID:
17701137
30.

Secretory phospholipase A2 of group IIA: is it an offensive or a defensive player during atherosclerosis and other inflammatory diseases?

Menschikowski M, Hagelgans A, Siegert G.

Prostaglandins Other Lipid Mediat. 2006 Mar;79(1-2):1-33. Epub 2005 Dec 27. Review.

PMID:
16516807
31.

Mice lacking the nuclear pore complex protein ALADIN show female infertility but fail to develop a phenotype resembling human triple A syndrome.

Huebner A, Mann P, Rohde E, Kaindl AM, Witt M, Verkade P, Jakubiczka S, Menschikowski M, Stoltenburg-Didinger G, Koehler K.

Mol Cell Biol. 2006 Mar;26(5):1879-87.

32.

The relevance of the detection of troponins to the forensic diagnosis of cardiac contusion.

Peter J, Kirchner A, Kuhlisch E, Menschikowski M, Neef B, Dressler J.

Forensic Sci Int. 2006 Jul 13;160(2-3):127-33. Epub 2005 Nov 2.

PMID:
16269219
33.

Impact of glucagon response on postprandial hyperglycemia in men with impaired glucose tolerance and type 2 diabetes mellitus.

Henkel E, Menschikowski M, Koehler C, Leonhardt W, Hanefeld M.

Metabolism. 2005 Sep;54(9):1168-73.

PMID:
16125528
34.

Statins potentiate the IFN-gamma-induced upregulation of group IIA phospholipase A2 in human aortic smooth muscle cells and HepG2 hepatoma cells.

Menschikowski M, Hagelgans A, Heyne B, Hempel U, Neumeister V, Goez P, Jaross W, Siegert G.

Biochim Biophys Acta. 2005 Apr 15;1733(2-3):157-71. Epub 2005 Jan 22.

PMID:
15863363
35.
36.

Increased hepatic cholesterol accumulation in transgenic mice overexpressing human secretory phospholipase A2 group IIA.

Eckey R, Menschikowski M, Lattke P, Jaross W.

Inflammation. 2004 Apr;28(2):59-65.

PMID:
15379211
37.

Omega-3 fatty acids improve liver and pancreas function in postoperative cancer patients.

Heller AR, Rössel T, Gottschlich B, Tiebel O, Menschikowski M, Litz RJ, Zimmermann T, Koch T.

Int J Cancer. 2004 Sep 10;111(4):611-6.

38.

Adrenocortical hormones in survivors and nonsurvivors of severe sepsis: diverse time course of dehydroepiandrosterone, dehydroepiandrosterone-sulfate, and cortisol.

Marx C, Petros S, Bornstein SR, Weise M, Wendt M, Menschikowski M, Engelmann L, Höffken G.

Crit Care Med. 2003 May;31(5):1382-8.

PMID:
12771606
39.

Biological effects of secretory phospholipase A(2) group IIA on lipoproteins and in atherogenesis.

Jaross W, Eckey R, Menschikowski M.

Eur J Clin Invest. 2002 Jun;32(6):383-93. Review.

PMID:
12059982
40.

Different effects of acarbose and glibenclamide on proinsulin and insulin profiles in people with Type 2 diabetes.

Hanefeld M, Haffner SM, Menschikowski M, Koehler C, Temelkova-Kurktschiev T, Wildbrett J, Fischer S.

Diabetes Res Clin Pract. 2002 Mar;55(3):221-7.

PMID:
11850098
41.

[Urinary concentration of collagen metabolites in endoprosthesis loosening].

Witzleb WC, Menschikowski M.

Z Orthop Ihre Grenzgeb. 2001 May-Jun;139(3):240-4. German.

PMID:
11486627
43.

Interleukin-1, interleukin-6 and myocardial enzyme response after coronary artery bypass grafting - a prospective randomized comparison of the conventional and three minimally invasive surgical techniques.

Gulielmos V, Menschikowski M, Dill H, Eller M, Thiele S, Tugtekin SM, Jaross W, Schueler S.

Eur J Cardiothorac Surg. 2000 Nov;18(5):594-601.

PMID:
11053823
44.

Impaired glucose tolerance (IGT) is not associated with disturbed homocysteine metabolism.

Pixa A, Pietzsch J, Julius U, Menschikowski M, Hanefeld M.

Amino Acids. 2000;18(3):289-98.

PMID:
10901625
45.

Expression of secretory group IIA phospholipase A(2) in relation to the presence of microbial agents, macrophage infiltrates, and transcripts of proinflammatory cytokines in human aortic tissues.

Menschikowski M, Rosner-Schiering A, Eckey R, Mueller E, Koch R, Jaross W.

Arterioscler Thromb Vasc Biol. 2000 Mar;20(3):751-62.

PMID:
10712401
46.

Analysis of secretory group II phospholipase A2 expression in human aortic tissue in dependence on the degree of atherosclerosis.

Schiering A, Menschikowski M, Mueller E, Jaross W.

Atherosclerosis. 1999 May;144(1):73-8.

PMID:
10381280
47.
48.
49.
50.

Secretory group II phospholipase A2 in human atherosclerotic plaques.

Menschikowski M, Kasper M, Lattke P, Schiering A, Schiefer S, Stockinger H, Jaross W.

Atherosclerosis. 1995 Dec;118(2):173-81.

PMID:
8770312

Supplemental Content

Loading ...
Support Center